TMCnet News
PWRM.OB and RNIN Stock Report Brough to you by StockHotTips.comPower 3 Medical Products Inc. (PWRM.OB) BC-SeraPro? was developed and its performance characteristics determined by the PWRM Laboratories. BC-SeraPro? is an ideal diagnostic test to evaluate breast cancer abnormalities found by mammogram or breast examination. PWRM strives to become the premier biotechnology company specializing in the commercialization of proteomics IP for the diagnosis and treatment of disease by using cutting edge technologies, world class quality procedures and superior research methodologies. BC-SeraPro? could detect the disease at a point when treatment is more effective, less expensive, or both. The test would distinguish women who should have a biopsy from those who can safely avoid one. How It Works BC-SeraPro? is a blood serum test designed to diagnose breast cancer in individuals. The test is based on proteomic technology in which a blood serum sample drawn from a patient will monitor the concentration of each protein biomarker residing in a panel of blood serum protein biomarkers to determine if a patient has breast cancer. The BC-SeraPro? test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient's serum sample is compared to the PWRMs' patient database. About Power3 Medical Power3 Medical Products, Inc., a development stage company, engages in commercializing its intellectual properties in the area of diagnosis and treatment of breast cancer, amyotrophic lateral sclerosis (ALS), Alzheimers disease, and Parkinsons disease. Its product candidates include BC-SeraPro, a blood serum protein breast cancer test for the diagnosis of breast cancer and to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. ******************************************* Wireless Ronin Technologies, Inc. (Nasdaq:RNIN) Wireless Ronin Technologies, Inc. (Nasdaq:RNIN), a Minneapolis-based digital signage provider, announced today that it has completed the first stage of the RoninCast® digital signage deployment with Leroy Signs, the sign vendor for Mall of America, the nation's largest retail and entertainment complex. The Mall of America's new Southside Renovation will feature 20 RoninCast digital signs and is part of the advertising monument signage program which includes the installation of RoninCast digital signage as part of their overall renovation plans. In addition to providing the hardware and software, WRT will monitor the network health through the NOC and deploy, create and schedule content as needed for this program. The screens will be arrayed throughout the mall and will be highly visible to all passing foot traffic. Featuring advertising for Mall of America stores, restaurants and entertainment venues as well as special events, the system will ensure that Mall of America guests get the most from their shopping, dining and entertainment experience with up to the minute information. Once the renovations are completed, WRT will have installed throughout the Mall of America. About Wireless Ronin Technologies, Inc. Wireless Ronin Technologies has developed RoninCast® software as a complete solution designed to address the evolving digital signage marketplace. RoninCast® software enables clients to manage digital signage networks from one central location and provides turnkey solutions in the digital signage marketplace. The RoninCast® software suite facilitates customized distribution with network management, playlist creation and scheduling, and database integration. Wireless Ronin offers an array of services to support RoninCast® software including consulting, creative development, project management, installation, and training. The company's common stock trades on the NASDAQ Global Market under the symbol "RNIN". As a community-building service, TMCnet allows user submitted content which is not always proofed by TMCnet editors. If you feel this entry is of inferior quality or wish to report it for some reason, please forward the URL to "webedit [AT] tmcnet [DOT] com" with your comments. |